financetom
Business
financetom
/
Business
/
Nexalin Technology Shares Rise After Clinical Trial Set for Halo Headset in Traumatic Brain Injuries
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nexalin Technology Shares Rise After Clinical Trial Set for Halo Headset in Traumatic Brain Injuries
Oct 22, 2024 12:44 PM

03:25 PM EDT, 10/22/2024 (MT Newswires) -- Nexalin Technology ( NXL ) shares rose 15% in recent trading Tuesday after the company announced a planned clinical trial for its Gen-3 Halo headset to treat victims of traumatic brain injury.

The trial is in collaboration with the University of California, San Diego, the company said Tuesday in a statement.

The headset will be used in a virtual clinic model, and the trial will evaluate the effectiveness of the device on brain activity and symptom relief in veterans with mild traumatic brain injury, the company said.

Price: 1.71, Change: +0.23, Percent Change: +15.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Aspen Insurance Set to be Acquired by Japan's Sompo for $3.4 Billion
Market Chatter: Aspen Insurance Set to be Acquired by Japan's Sompo for $3.4 Billion
Aug 27, 2025
07:57 AM EDT, 08/27/2025 (MT Newswires) -- Aspen Insurance ( AHL ) , a specialty insurer owned by Apollo Global Management ( APO ) , is in the final stages of talks to be acquired by Japanese insurance group Sompo Holdings for $3.4 billion, Nikkei Asia reported Wednesday. Shares of Aspen were up 10% in recent Wednesday premarket activity. (Market...
REX American Resources to Implement a 2-for-1 Stock Split
REX American Resources to Implement a 2-for-1 Stock Split
Aug 27, 2025
07:56 AM EDT, 08/27/2025 (MT Newswires) -- REX American Resources ( REX ) said Wednesday that its board has approved a 2-for-1 stock split, distributing one additional share for every share owned as a stock dividend. The company said its outstanding shares will increase to 33.1 million from about 16.5 million. REX American Resources ( REX ) also said it...
BioXcel Says At-Home Agitation Treatment Phase 3 Trial Meets Primary Endpoint
BioXcel Says At-Home Agitation Treatment Phase 3 Trial Meets Primary Endpoint
Aug 27, 2025
07:59 AM EDT, 08/27/2025 (MT Newswires) -- BioXcel Therapeutics ( BTAI ) said Wednesday that a phase 3 trial of BXCL501 met its primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia. The results showed no discontinuations due to tolerability in the BXCL501 arm, the company said. The trial...
Telesat Names Donald Tremblay as New CFO
Telesat Names Donald Tremblay as New CFO
Aug 27, 2025
07:59 AM EDT, 08/27/2025 (MT Newswires) -- Telesat ( TSAT ) said Wednesday it appointed Donald Tremblay as its new finance chief, effective Oct. 20. Tremblay has over 35 years of experience in financial leadership, including roles at Champion Iron, Transalta, and Brookfield Renewable, the company said. He will succeed Andrew Browne, who announced his retirement in March after working...
Copyright 2023-2026 - www.financetom.com All Rights Reserved